U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07752251) titled 'A Study Of Subscalp Placement Of The LINQII Device' on Aug. 03.
Brief Summary: The purpose of this to evaluate the capability of the FDA approved Medtronic LINQ II device (implantable cardiac monitoring device) to record EEG signals when placed temporarily in the subscalp space in patients undergoing cranial neurosurgery. No disease-directed therapeutic efficacy endpoints will be studied.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Cranial Neurosurgery
Intervention:
DEVICE: Medtronic LINQII
Bilateral LINQII devices will be implanted under the scalp during surgery to obtain approximately 30 minutes of bra...